Lipoprotein lipase deficiency in chronic kidney disease is accompanied by down-regulation of endothelial GPIHBP1 expression. - Wikidata - wikimedia - TriplyDB

Lipoprotein lipase deficiency in chronic kidney disease is accompanied by down-regulation of endothelial GPIHBP1 expression.

Lipoprotein lipase deficiency in chronic kidney disease is accompanied by down-regulation of endothelial GPIHBP1 expression.

http://www.wikidata.org/entity/Q41980428

about

Modified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic Toxins Residual Cardiovascular Risk in Chronic Kidney Disease: Role of High-density Lipoprotein Dialysis Procedures Alter Metabolic Conditions.Relationship between lipoprotein lipase gene polymorphism and hemorrhagic stroke in a Chinese population Impaired postprandial lipemic response in chronic kidney disease.White adipose tissue overproduces the lipid-mobilizing factor zinc α2-glycoprotein in chronic kidney disease.Reasons for the lack of salutary effects of cholesterol-lowering interventions in end-stage renal disease populations.Role of dyslipidemia in impairment of energy metabolism, oxidative stress, inflammation and cardiovascular disease in chronic kidney disease.Lipoprotein metabolism and CKD: overview.Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences.The role of adipose tissue asymmetric dimethylarginine/dimethylarginine dimethylaminohydrolase pathway in adipose tissue phenotype and metabolic abnormalities in subtotally nephrectomized rats.Dysregulation of hepatic fatty acid metabolism in chronic kidney disease.Dyslipidaemia in nephrotic syndrome: mechanisms and treatment.An Integrated Lipidomics and Phenotype Study Reveals Protective Effect and Biochemical Mechanism of Traditionally Used Alisma orientale Juzepzuk in Chronic Kidney Disease.

P2860

Q28074264-F3E3D43F-952C-4012-8FAE-DD2F1FC4E316 Q28083619-2071A85D-7685-4BD4-BAB7-B1C696E855BD Q33851814-EFE3601C-29A8-4B59-A4DE-8F9C0E002248 Q36183165-7FAC4D6B-1793-4C37-88D5-756CCFC70C46 Q37017211-D4A2DE75-1AFB-46C5-8D8D-D634C5148049 Q37609992-999CE7E9-9E80-4671-A607-D7F46F7B860A Q38076217-28D190ED-B889-484D-8E2A-BD82AE31B25F Q38131300-323B5140-2182-428A-A70E-E04727AAAC1D Q38139864-E188E39B-0294-4BF7-871B-6EDA12B788C7 Q38831462-BC917679-5F6E-408C-AD27-65A37E5A006A Q42818947-036E17CF-207A-4624-925B-7152DB3F885A Q43247391-9DFFF689-5756-48DD-A41D-ED45B0FDB826 Q47363893-7C56C5F8-9655-4846-AC53-E222B115BC1D Q50326733-F7A0EA2C-609C-4EFF-8D87-1DDF6ABFA054

P2860

Lipoprotein lipase deficiency in chronic kidney disease is accompanied by down-regulation of endothelial GPIHBP1 expression.

http://www.wikidata.org/entity/Q41980428

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Lipoprotein lipase deficiency ...... ndothelial GPIHBP1 expression.

@en

type

label

Lipoprotein lipase deficiency ...... ndothelial GPIHBP1 expression.

@en

prefLabel

Lipoprotein lipase deficiency ...... ndothelial GPIHBP1 expression.

@en

P1433

Q41980428-D867D602-02D4-4960-A0FE-3F87FFD7A6F6

P1476

Q41980428-CB20C797-A858-4A0B-BDCC-2CBE5EC6908B

P2093

Q41980428-311E0A07-67B7-414E-B758-97C3A7B74C43

Q41980428-4AE55C24-A156-43FC-825E-E40917301C81

Q41980428-7021BF16-E796-4DDC-A6D3-BE51B3423277

Q41980428-D868E002-22D3-42AA-B155-24BE184005D4

Q41980428-FF1C09FF-B691-4245-B881-197B4FBA8706

P2860

Q41980428-132A01D5-9DAB-4367-BE0A-07DBB131BDB9

Q41980428-17707567-C729-4006-8455-3907713107D3

Q41980428-1F7B9DC8-335B-4858-818A-AC24A661FB47

Q41980428-21C6C16D-48AF-44B1-844E-4B6297CE3E0C

Q41980428-22C56713-7D57-4689-97FB-C470FBFE2996

Q41980428-243A0516-72E2-47DE-A76D-6E954818199C

Q41980428-492D44BF-1856-4612-B404-F1A874A7CF9B

Q41980428-61071491-06E9-49AA-B634-822C6C15E486

Q41980428-62D162FE-E880-4BDE-B334-4C39EAD93A52

Q41980428-7363398E-ACE7-450C-83AF-32740559D407

P2888

Q41980428-9F0675A9-DC2C-478E-A5B3-D7D505AF9025

P304

Q41980428-F86ABB84-9B7B-4CCD-B2F5-ECD197E67EF4

P31

Q41980428-AD332B95-28BA-4A7D-B483-441BDF3A5BA6

P356

Q41980428-E06F18AA-22CB-4BD1-A1EC-EDD8864012B9

P433

Q41980428-FAF6DF2A-5A18-48F3-A638-4B4FA789E51C

P478

Q41980428-DCCC95CD-D0A6-42F5-89E8-1DFC25FDC1F2

P577

Q41980428-4CC4450C-1B5A-43A2-A547-73D3ED081A27

P5875

Q41980428-D8A6DFDE-C33E-4E51-8094-A858C53F2A4D

P698

Q41980428-5648B80C-F3BA-4D92-B5D0-E1ED7A9900AC

P921

Q41980428-06CD486A-F102-46B0-8260-DDBB692FF8F8

Q41980428-E9370C3F-6E0A-4F01-A45C-CE672A4DF120

P932

Q41980428-B69BD6D8-3640-49D1-894D-774DED851FE9

P356

S10157-011-0549-3

P1433

Clinical and experimental nephrology

P1476

Lipoprotein lipase deficiency ...... ndothelial GPIHBP1 expression.

@en

P2093

Jun Yuan

http://www.w3.org/2001/XMLSchema#string

Keith C Norris

http://www.w3.org/2001/XMLSchema#string

Nosratola D Vaziri

http://www.w3.org/2001/XMLSchema#string

Susanne B Nicholas

http://www.w3.org/2001/XMLSchema#string

Zhenmin Ni

http://www.w3.org/2001/XMLSchema#string

P2860

Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons

GPIHBP1: an endothelial cell molecule important for the lipolytic processing of chylomicrons.

Lipoprotein size and susceptibility to atherosclerosis--insights from genetically modified mouse models

High-calorie diet with moderate protein restriction prevents cachexia and ameliorates oxidative stress, inflammation and proteinuria in experimental chronic kidney disease.

Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences.

Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney.

GPIHBP1, a GPI-anchored protein required for the lipolytic processing of triglyceride-rich lipoproteins

Abnormalities in hepatic lipase in chronic renal failure: role of excess parathyroid hormone.

Causes of dysregulation of lipid metabolism in chronic renal failure.

HDL metabolism and activity in chronic kidney disease.

P2888

s10157-011-0549-3

P304

238-243

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10157-011-0549-3

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2011-10-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51727392

http://www.w3.org/2001/XMLSchema#string

P698

22009636

http://www.w3.org/2001/XMLSchema#string

P921

P932

3417131

http://www.w3.org/2001/XMLSchema#string